nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PLA2G4A—autistic disorder	0.657	0.828	CbGaD
Niflumic Acid—PTGS2—autistic disorder	0.137	0.173	CbGaD
Niflumic Acid—CLCNKA—digestive system—autistic disorder	0.00641	0.0904	CbGeAlD
Niflumic Acid—PLA2G1B—mouth—autistic disorder	0.00572	0.0807	CbGeAlD
Niflumic Acid—CLCNKA—head—autistic disorder	0.00523	0.0737	CbGeAlD
Niflumic Acid—CLCNKA—cerebellum—autistic disorder	0.00466	0.0658	CbGeAlD
Niflumic Acid—SLC16A7—forebrain—autistic disorder	0.00304	0.0429	CbGeAlD
Niflumic Acid—SLC16A7—telencephalon—autistic disorder	0.00279	0.0394	CbGeAlD
Niflumic Acid—PLA2G1B—digestive system—autistic disorder	0.00253	0.0357	CbGeAlD
Niflumic Acid—UGT1A9—digestive system—autistic disorder	0.00232	0.0327	CbGeAlD
Niflumic Acid—PLA2G1B—head—autistic disorder	0.00207	0.0291	CbGeAlD
Niflumic Acid—PLA2G1B—nervous system—autistic disorder	0.00196	0.0276	CbGeAlD
Niflumic Acid—SLC16A1—eye—autistic disorder	0.00195	0.0275	CbGeAlD
Niflumic Acid—PLA2G1B—central nervous system—autistic disorder	0.00189	0.0266	CbGeAlD
Niflumic Acid—SLC16A1—telencephalon—autistic disorder	0.00178	0.0251	CbGeAlD
Niflumic Acid—SLC16A7—head—autistic disorder	0.00174	0.0246	CbGeAlD
Niflumic Acid—SLC16A7—nervous system—autistic disorder	0.00165	0.0233	CbGeAlD
Niflumic Acid—SLC16A7—central nervous system—autistic disorder	0.00159	0.0224	CbGeAlD
Niflumic Acid—SLC16A7—cerebellum—autistic disorder	0.00155	0.0219	CbGeAlD
Niflumic Acid—PLA2G1B—brain—autistic disorder	0.0015	0.0211	CbGeAlD
Niflumic Acid—SLC16A1—digestive system—autistic disorder	0.00136	0.0192	CbGeAlD
Niflumic Acid—PTGS2—mouth—autistic disorder	0.00132	0.0186	CbGeAlD
Niflumic Acid—SLC16A7—brain—autistic disorder	0.00126	0.0178	CbGeAlD
Niflumic Acid—PLA2G4A—nervous system—autistic disorder	0.00119	0.0168	CbGeAlD
Niflumic Acid—PLA2G4A—central nervous system—autistic disorder	0.00115	0.0162	CbGeAlD
Niflumic Acid—SLC16A1—head—autistic disorder	0.00111	0.0156	CbGeAlD
Niflumic Acid—SLC16A1—nervous system—autistic disorder	0.00105	0.0148	CbGeAlD
Niflumic Acid—SLC16A1—central nervous system—autistic disorder	0.00101	0.0143	CbGeAlD
Niflumic Acid—SLC16A1—cerebellum—autistic disorder	0.000988	0.0139	CbGeAlD
Niflumic Acid—PLA2G4A—brain—autistic disorder	0.000911	0.0129	CbGeAlD
Niflumic Acid—PTGS1—forebrain—autistic disorder	0.000868	0.0122	CbGeAlD
Niflumic Acid—PTGS2—forebrain—autistic disorder	0.000829	0.0117	CbGeAlD
Niflumic Acid—SLC16A1—brain—autistic disorder	0.000802	0.0113	CbGeAlD
Niflumic Acid—PTGS1—telencephalon—autistic disorder	0.000798	0.0113	CbGeAlD
Niflumic Acid—PTGS2—telencephalon—autistic disorder	0.000762	0.0108	CbGeAlD
Niflumic Acid—Floctafenine—PTGS2—autistic disorder	0.000648	0.719	CrCbGaD
Niflumic Acid—PTGS1—digestive system—autistic disorder	0.000609	0.00859	CbGeAlD
Niflumic Acid—PTGS2—digestive system—autistic disorder	0.000582	0.00821	CbGeAlD
Niflumic Acid—PTGS1—head—autistic disorder	0.000497	0.00701	CbGeAlD
Niflumic Acid—PTGS2—head—autistic disorder	0.000475	0.0067	CbGeAlD
Niflumic Acid—PTGS1—nervous system—autistic disorder	0.000471	0.00665	CbGeAlD
Niflumic Acid—PTGS1—central nervous system—autistic disorder	0.000453	0.0064	CbGeAlD
Niflumic Acid—PTGS2—nervous system—autistic disorder	0.00045	0.00635	CbGeAlD
Niflumic Acid—PTGS2—central nervous system—autistic disorder	0.000433	0.00612	CbGeAlD
Niflumic Acid—PTGS2—cerebellum—autistic disorder	0.000424	0.00598	CbGeAlD
Niflumic Acid—PTGS1—brain—autistic disorder	0.00036	0.00508	CbGeAlD
Niflumic Acid—PTGS2—brain—autistic disorder	0.000344	0.00486	CbGeAlD
Niflumic Acid—Mefenamic acid—PTGS2—autistic disorder	0.000253	0.281	CrCbGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—DRD1—autistic disorder	3.71e-05	0.000275	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SLC25A12—autistic disorder	3.63e-05	0.000269	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GRM8—autistic disorder	3.62e-05	0.000268	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—EXT1—autistic disorder	3.6e-05	0.000267	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC6A8—autistic disorder	3.6e-05	0.000267	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—DRD3—autistic disorder	3.6e-05	0.000266	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TCN2—autistic disorder	3.59e-05	0.000266	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—autistic disorder	3.56e-05	0.000264	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—MTHFR—autistic disorder	3.53e-05	0.000262	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SLC19A1—autistic disorder	3.53e-05	0.000262	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MAOB—autistic disorder	3.53e-05	0.000262	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL5—autistic disorder	3.52e-05	0.000261	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—DHFR—autistic disorder	3.51e-05	0.00026	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—WNT2—autistic disorder	3.51e-05	0.00026	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—PRKCB—autistic disorder	3.48e-05	0.000258	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—autistic disorder	3.48e-05	0.000258	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CALCA—autistic disorder	3.48e-05	0.000258	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GHR—autistic disorder	3.45e-05	0.000256	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC25A12—autistic disorder	3.44e-05	0.000255	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—NOS2—autistic disorder	3.44e-05	0.000255	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DAO—autistic disorder	3.44e-05	0.000255	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ADA—autistic disorder	3.42e-05	0.000254	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDE4A—autistic disorder	3.4e-05	0.000252	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	3.38e-05	0.000251	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—autistic disorder	3.36e-05	0.000249	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC19A1—autistic disorder	3.35e-05	0.000248	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—PIK3CG—autistic disorder	3.33e-05	0.000247	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—UPB1—autistic disorder	3.3e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—EGF—autistic disorder	3.29e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—APOE—autistic disorder	3.29e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—TPH2—autistic disorder	3.28e-05	0.000243	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—HRAS—autistic disorder	3.25e-05	0.000241	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	3.24e-05	0.00024	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	3.24e-05	0.00024	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—DPYD—autistic disorder	3.23e-05	0.000239	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AVPR1A—autistic disorder	3.19e-05	0.000236	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ADSL—autistic disorder	3.15e-05	0.000233	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—RORA—autistic disorder	3.12e-05	0.000231	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	3.11e-05	0.000231	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—XDH—autistic disorder	3.09e-05	0.000229	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MAPK1—autistic disorder	3.08e-05	0.000228	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VIP—autistic disorder	3.08e-05	0.000228	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GRM5—autistic disorder	3.08e-05	0.000228	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM5—autistic disorder	3.06e-05	0.000227	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ASMT—autistic disorder	3.06e-05	0.000227	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IGF1—autistic disorder	3.05e-05	0.000226	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	3.03e-05	0.000225	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—STX1A—autistic disorder	3.03e-05	0.000224	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NPAS2—autistic disorder	3.03e-05	0.000224	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IL2—autistic disorder	3.01e-05	0.000223	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CACNA1C—autistic disorder	3e-05	0.000222	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL6—autistic disorder	2.99e-05	0.000222	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—OXTR—autistic disorder	2.98e-05	0.000221	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PIK3CG—autistic disorder	2.97e-05	0.00022	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SCT—autistic disorder	2.95e-05	0.000219	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MAOB—autistic disorder	2.92e-05	0.000217	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TCN2—autistic disorder	2.92e-05	0.000217	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ADRB2—autistic disorder	2.91e-05	0.000216	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—SERPINE1—autistic disorder	2.9e-05	0.000215	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.89e-05	0.000214	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC25A12—autistic disorder	2.88e-05	0.000213	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—STX1A—autistic disorder	2.87e-05	0.000213	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—POMC—autistic disorder	2.82e-05	0.000209	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADM—autistic disorder	2.82e-05	0.000209	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GABBR1—autistic disorder	2.82e-05	0.000209	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC19A1—autistic disorder	2.8e-05	0.000208	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ADA—autistic disorder	2.79e-05	0.000207	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.78e-05	0.000206	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TCN2—autistic disorder	2.77e-05	0.000205	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EIF4E—autistic disorder	2.77e-05	0.000205	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.76e-05	0.000204	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP19A1—autistic disorder	2.75e-05	0.000204	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDE4B—autistic disorder	2.74e-05	0.000203	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AVP—autistic disorder	2.74e-05	0.000203	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—DHFR—autistic disorder	2.73e-05	0.000202	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TPH2—autistic disorder	2.72e-05	0.000201	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—WNT2—autistic disorder	2.69e-05	0.000199	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—DPYD—autistic disorder	2.67e-05	0.000198	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—OPRM1—autistic disorder	2.66e-05	0.000197	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.64e-05	0.000196	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	2.58e-05	0.000191	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	2.57e-05	0.000191	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—COMT—autistic disorder	2.56e-05	0.000189	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—RORA—autistic disorder	2.54e-05	0.000189	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTP1—autistic disorder	2.54e-05	0.000189	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MAOA—autistic disorder	2.54e-05	0.000188	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.51e-05	0.000186	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ADSL—autistic disorder	2.5e-05	0.000185	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CACNA1C—autistic disorder	2.49e-05	0.000184	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CAT—autistic disorder	2.48e-05	0.000183	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—XDH—autistic disorder	2.45e-05	0.000181	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GZMB—autistic disorder	2.43e-05	0.00018	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—STX1A—autistic disorder	2.4e-05	0.000178	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NPAS2—autistic disorder	2.4e-05	0.000178	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.39e-05	0.000177	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MAOB—autistic disorder	2.38e-05	0.000177	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL6—autistic disorder	2.37e-05	0.000175	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR1B—autistic disorder	2.36e-05	0.000175	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—OXT—autistic disorder	2.36e-05	0.000175	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IL2—autistic disorder	2.34e-05	0.000174	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PLA2G4A—autistic disorder	2.34e-05	0.000173	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTM1—autistic disorder	2.34e-05	0.000173	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TCN2—autistic disorder	2.32e-05	0.000172	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—MAPK1—autistic disorder	2.31e-05	0.000171	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.3e-05	0.000171	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR2A—autistic disorder	2.28e-05	0.000169	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.27e-05	0.000168	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—DHFR—autistic disorder	2.26e-05	0.000168	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTGS2—autistic disorder	2.25e-05	0.000167	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GPX1—autistic disorder	2.24e-05	0.000166	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TPH2—autistic disorder	2.22e-05	0.000164	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RPL10—autistic disorder	2.22e-05	0.000164	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ADA—autistic disorder	2.21e-05	0.000164	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—DRD1—autistic disorder	2.19e-05	0.000163	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TSC1—autistic disorder	2.19e-05	0.000163	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.19e-05	0.000162	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—DPYD—autistic disorder	2.18e-05	0.000162	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP19A1—autistic disorder	2.14e-05	0.000158	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NTRK2—autistic disorder	2.13e-05	0.000158	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—DRD3—autistic disorder	2.12e-05	0.000157	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.1e-05	0.000155	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	2.1e-05	0.000155	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL5—autistic disorder	2.08e-05	0.000154	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MTHFR—autistic disorder	2.07e-05	0.000153	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CALCA—autistic disorder	2.05e-05	0.000152	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.05e-05	0.000152	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CACNA1C—autistic disorder	2.03e-05	0.00015	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—RORA—autistic disorder	2.02e-05	0.00015	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.01e-05	0.000149	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PRKCB—autistic disorder	2e-05	0.000148	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—COMT—autistic disorder	1.99e-05	0.000147	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTP1—autistic disorder	1.98e-05	0.000147	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MAOA—autistic disorder	1.97e-05	0.000146	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTEN—autistic disorder	1.96e-05	0.000146	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.95e-05	0.000144	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CAT—autistic disorder	1.93e-05	0.000143	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APOE—autistic disorder	1.92e-05	0.000143	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PIK3CG—autistic disorder	1.91e-05	0.000142	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.91e-05	0.000141	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MAOB—autistic disorder	1.89e-05	0.00014	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—HRAS—autistic disorder	1.85e-05	0.000137	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—DHFR—autistic disorder	1.84e-05	0.000137	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—POMC—autistic disorder	1.82e-05	0.000135	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTM1—autistic disorder	1.82e-05	0.000135	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRL—autistic disorder	1.81e-05	0.000134	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.8e-05	0.000133	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—MAPK1—autistic disorder	1.79e-05	0.000133	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP19A1—autistic disorder	1.77e-05	0.000131	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TPH2—autistic disorder	1.76e-05	0.00013	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—DHFR—autistic disorder	1.75e-05	0.00013	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GPX1—autistic disorder	1.74e-05	0.000129	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PIK3CG—autistic disorder	1.74e-05	0.000129	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DPYD—autistic disorder	1.73e-05	0.000128	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADRB2—autistic disorder	1.72e-05	0.000128	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.66e-05	0.000123	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—POMC—autistic disorder	1.65e-05	0.000122	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—COMT—autistic disorder	1.65e-05	0.000122	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTP1—autistic disorder	1.64e-05	0.000121	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MAOA—autistic disorder	1.64e-05	0.000121	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.63e-05	0.00012	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AVP—autistic disorder	1.62e-05	0.00012	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF2—autistic disorder	1.61e-05	0.000119	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CACNA1C—autistic disorder	1.61e-05	0.000119	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—autistic disorder	1.61e-05	0.000119	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CAT—autistic disorder	1.6e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CALCA—autistic disorder	1.57e-05	0.000117	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.55e-05	0.000115	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.55e-05	0.000115	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PLA2G4A—autistic disorder	1.51e-05	0.000112	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTM1—autistic disorder	1.51e-05	0.000112	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOE—autistic disorder	1.5e-05	0.000111	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MEF2C—autistic disorder	1.48e-05	0.00011	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DHFR—autistic disorder	1.46e-05	0.000108	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP19A1—autistic disorder	1.44e-05	0.000107	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GPX1—autistic disorder	1.44e-05	0.000107	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ITGB3—autistic disorder	1.44e-05	0.000107	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—HRAS—autistic disorder	1.44e-05	0.000107	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRL—autistic disorder	1.39e-05	0.000103	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.36e-05	0.0001	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PIK3CG—autistic disorder	1.35e-05	0.0001	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR2A—autistic disorder	1.35e-05	9.97e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL2—autistic disorder	1.34e-05	9.96e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—COMT—autistic disorder	1.34e-05	9.95e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTP1—autistic disorder	1.34e-05	9.9e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MAOA—autistic disorder	1.33e-05	9.88e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—autistic disorder	1.33e-05	9.87e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—autistic disorder	1.32e-05	9.77e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CAT—autistic disorder	1.3e-05	9.64e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—POMC—autistic disorder	1.29e-05	9.52e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TSC2—autistic disorder	1.28e-05	9.47e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LEP—autistic disorder	1.25e-05	9.27e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOE—autistic disorder	1.25e-05	9.27e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOE—autistic disorder	1.24e-05	9.19e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PLA2G4A—autistic disorder	1.23e-05	9.1e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTM1—autistic disorder	1.23e-05	9.1e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRKCB—autistic disorder	1.18e-05	8.74e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GPX1—autistic disorder	1.18e-05	8.72e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTEN—autistic disorder	1.15e-05	8.52e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP19A1—autistic disorder	1.15e-05	8.5e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PIK3CG—autistic disorder	1.13e-05	8.37e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APC—autistic disorder	1.13e-05	8.37e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PIK3CG—autistic disorder	1.12e-05	8.29e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EGF—autistic disorder	1.12e-05	8.27e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—autistic disorder	1.09e-05	8.04e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.08e-05	7.98e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—POMC—autistic disorder	1.07e-05	7.96e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—COMT—autistic disorder	1.07e-05	7.9e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—POMC—autistic disorder	1.06e-05	7.89e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTP1—autistic disorder	1.06e-05	7.86e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MAOA—autistic disorder	1.06e-05	7.84e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF1—autistic disorder	1.03e-05	7.66e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CAT—autistic disorder	1.03e-05	7.65e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—autistic disorder	1.03e-05	7.62e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—MAPK1—autistic disorder	1.03e-05	7.62e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HLA-A—autistic disorder	1.03e-05	7.6e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—autistic disorder	1.03e-05	7.6e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOE—autistic disorder	1.01e-05	7.49e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SERPINE1—autistic disorder	9.82e-06	7.27e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TSC2—autistic disorder	9.79e-06	7.25e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PLA2G4A—autistic disorder	9.75e-06	7.22e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM1—autistic disorder	9.75e-06	7.22e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOE—autistic disorder	9.58e-06	7.1e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GPX1—autistic disorder	9.34e-06	6.92e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIK3CG—autistic disorder	9.12e-06	6.76e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTEN—autistic disorder	8.94e-06	6.62e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS2—autistic disorder	8.93e-06	6.61e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—POMC—autistic disorder	8.68e-06	6.43e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APC—autistic disorder	8.65e-06	6.41e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—autistic disorder	8.62e-06	6.38e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EGF—autistic disorder	8.55e-06	6.33e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—autistic disorder	8.49e-06	6.29e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HRAS—autistic disorder	8.26e-06	6.12e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOE—autistic disorder	8.02e-06	5.94e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2—autistic disorder	7.94e-06	5.89e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—autistic disorder	7.9e-06	5.86e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SERPINE1—autistic disorder	7.52e-06	5.57e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTEN—autistic disorder	7.48e-06	5.54e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTEN—autistic disorder	7.41e-06	5.49e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIK3CG—autistic disorder	7.24e-06	5.36e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—autistic disorder	6.92e-06	5.13e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—POMC—autistic disorder	6.89e-06	5.11e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MAPK1—autistic disorder	6.08e-06	4.5e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTEN—autistic disorder	6.04e-06	4.47e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PTEN—autistic disorder	5.72e-06	4.24e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HRAS—autistic disorder	4.88e-06	3.62e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PTEN—autistic disorder	4.79e-06	3.55e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—autistic disorder	4.67e-06	3.46e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MAPK1—autistic disorder	4.65e-06	3.45e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HRAS—autistic disorder	3.74e-06	2.77e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—autistic disorder	3.58e-06	2.65e-05	CbGpPWpGaD
